For US residents only.

Novartis.

What Can I Expect to Pay for KISQALI?

The list price of KISQALI® (ribociclib) tablets is $5021-$12,553 based on the dose you're taking, but the amount you pay will depend on your insurance plan. The information below outlines what you may pay based on the type of insurance you have. Please speak with your insurance company or pharmacist to better understand your exact cost and the details of your plan.

Novartis Oncology is committed to making treatment with KISQALI as affordable as possible. You may qualify for financial assistance and other support based on your situation.

77% of KISQALI prescriptions cost between $0-$10 per month with the remaining prescriptions having a median cost of $38

 77% Chart with disclaimer

74% of KISQALI prescriptions cost between $0-$10 per month with the remaining prescriptions having a median cost of $485

 74% Chart with disclaimer

99% of KISQALI prescriptions cost between $0-$10 per month 

 99% Chart with disclaimer

We're committed to making treatment with KISQALI as affordable as possible. Read below to learn about ways you may be able to save on your KISQALI prescription.

 

1 FREE Treatment Cycle of KISQALI and/or FEMARA

Patients are eligible to receive a 1-treatment cycle supply of any one of the following at no cost.*

  • KISQALI® (ribociclib)
  • FEMARA® (letrozole)
  • letrozole
  • KISQALI + FEMARA
  • KISQALI + letrozole
  • KISQALI FEMARA Co-Pack

Call 1-800-282-7630 or visit www.FreeTreatmentVoucher.com to receive your free treatment voucher.

*No purchase required of the KISQALI FEMARA Co-Pack, or KISQALI or FEMARA (including generic letrozole). This offer is available for patients with a valid prescription for the KISQALI FEMARA Co-Pack, or for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product.

 

KISQALI 5-Treatment Cycle Access

Patients with commercial insurance who are still waiting for their coverage to take effect for the KISQALI FEMARA Co-Pack or KISQALI may be eligible for an additional supply of KISQALI that could continue for up to 5 treament cycles.

For more information, talk to your doctor or call 1-800-282-7630.

Limitations apply. Eligible patients must have commercial insurance, a completed Service Request Form, and be experiencing a delay in obtaining coverage for KISQALI. Program is not available to patients whose medications are reiumbursed in whole or in part by Medicare, Medicaid, Tricare, or any other federal or state program. No purchase necessary. Participation is not a guarantee of insurance coverage. Once coverage is approved, patients will no longer be eligible. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

 

KISQALI and/or FEMARA $0 Co-Pay

You may be eligible for immediate co-pay savings on your next prescription of KISQALI and/or FEMARA (including generic letrozole).

  • Eligible patients with private insurance may pay $o per month
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product

To find out if you are eligible for the Novartis Oncology Universal Co-Pay Program, call 1-877-577-7756 or visit www.CoPay.NovartisOncology.com.

Limitations apply. This offer is only available to patients with pricate insurance. The Program is NOT AVAILABLE for patients that are enrolled in Medicare, Medicaid, or any other federal or state health care program. Use of this offer for FEMARA (or generic letrozole) does not require a KISQALI prescription. Offer is NOT valid for purchases of FEMARA only by California or Masschusetts residents. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit www.CoPay.NovartisOncology.com or call 1-877-577-7756.

Find KISQALI treatment information and patient support resources at KISQALI.com.

6/19 KIS-1215790